PTAB Reverses §101 and §103 Rejections for Plant Extract December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal Board (PTAB) overturned ...
Search Results Search results for "PTAB101", has returned "10" results. Homepage PTAB Reverses §101 and §103 Rejections for Plant Extract December 13, 2022 Update by Grace Kim and Sara Pistilli,...
PTAB Reverses §101 and §103 Rejections for Plant Extract Attorney: Grace Kim December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal ...
PTAB Reverses §101 and §103 Rejections for Plant Extract Attorney: Grace Kim December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal ...
Category: PTAB101 Statutory" Obviousness-Type Double Patenting for Pharma Patents? June 20, 2019 As all patent practitioners know, obviousness-type double patenting is a judicially created doctrine ...
PTAB Reverses §101 and §103 Rejections for Plant Extract Attorney: Grace Kim December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal ...
PTAB Reverses §101 and §103 Rejections for Plant Extract Attorney: Grace Kim December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal ...
PTAB Reverses §101 and §103 Rejections for Plant Extract December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal Board (PTAB) overturned ...
In other words, the PTAB reversed the 101 rejection because the Examiner did not follow the USPTO’s guidance. In addition, this case should be a reminder that when the law (or guidance changes), it ...